Agree with DestinyL. Always at a disadvantage to shareholders Answer is to get stk price to revisit 2.95. Recession on the way, around Q2. Let's see where the price will be. Adage of buy low, sell high applies :p ‐-------‐---------------------‐--------------------------------- An astute post by AngTayKor
What is cheap? Cheap can get cheaper. Ever cheap until 2.95 before :p
December school holidays should have a lot of tourist from local and Singapore. Expected Q4 2022 results better than Q3 2023. Should be getting good dividend in March 2023.
Lecanemab causes brain to shrink even faster! -------------------------
Lecanemab and other drugs that remove amyloid have another side effect that is more mysterious: They seem to cause the brain to shrink.
That concerns scientists including Thambisetty.
"Brain shrinkage represents disease progression," he says. "What is a little worrying to me is that these drugs might be worsening the degenerative process."
Alzheimer's itself causes the brain to shrink, a sign that neurons are dying. So Thambisetty expected Alzheimer's drugs to limit shrinkage, rather than accelerate it.
So did Dr. David Knopman of the Mayo Clinic. "It's moving in the wrong direction," he said during a panel at the Alzheimer's meeting.
Thambisetty wants Eisai to publish detailed information about the changes in brain volume that occurred during its study of lecanemab.
@DestinyL, rate of brain atrophy is one of the endpoint measurement in lucidity trial. This is the purest form of biomarker in a clinical trial compared to reduction of amyloid deposits. Patients taking HMTM can see slower rate of brain atrophy.
I think some amyloid drugs are so harsh at clearing away amyloid plaques that somehow it even manage to clear away a little tau tangles. Hence can see some cognition slowdown but this is largely due to a small reduction in tau tangles. Eli lily keep touting their donanemab clears amyloid deposits faster n can even clear away some Tau tangles.
Post a Comment
People who like this
New Topic
You should check in on some of those fields below.
Title
Category
Comment
Confirmation
Click Confirm to delete this Forum Thread and all the associated comments.
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
DestinyL
4,746 posts
Posted by DestinyL > 2022-12-07 14:39 | Report Abuse
Drop is probably due to the RPT again. Shame on LKT